Skip to main content

Jantoven News

Study Compares Rivaroxaban, Warfarin With Apixaban for Cirrhosis, A-Fib

MONDAY, July 8, 2024 – For patients with cirrhosis and nonvalvular atrial fibrillation (AF), initiators of rivaroxaban or warfarin versus apixaban have significantly higher rates of major...

Warfarin Cuts Mortality, Thromboembolism After Valve Replacement

THURSDAY, Jan. 4, 2024 – Warfarin use after bioprosthetic surgical aortic valve replacement (sAVR) is associated with lower all-cause mortality and a decreased risk for thromboembolism compared with...

Bleeding Higher With Standard-Dose DOACs in Nonvalvular A-Fib

THURSDAY, Nov. 16, 2023 – For nursing home residents with nonvalvular atrial fibrillation, the rate of bleeding is higher with standard- versus reduced-dose direct acting oral anticoagulants...

FDA Medwatch Alert: Coumadin (warfarin sodium) for Injection by Bristol-Myers Squibb: Recall - Particulate Matter

ISSUE:  Bristol-Myers Squibb Company issued a voluntary recall of six lots of Coumadin for Injection, 5 mg single-use vials in the U.S. Visible particulate matter was found in a small number of ...

FDA Medwatch Alert: Warfarin 2 mg Tablets by Zydus Pharmaceuticals USA Inc.: Recall - Due to Oversized Tablets

ISSUE: Zydus Pharmaceuticals USA Inc. is voluntarily recalling one lot of Warfarin 2 mg Tablets, Lot #MM5767, expiration date June 2014 to the retail level. Four tablets of Warfarin 2 mg Tablets, Lot...

Ask a question

To post your own question to our community, sign in or create an account.

Further information

Related condition support groups

Deep Vein Thrombosis Prophylaxis after Knee Replacement Surgery, Deep Vein Thrombosis - First Event, Deep Vein Thrombosis - Recurrent Event, Myocardial Infarction, Heart Attack, Heart Failure, Congestive Heart Failure, Prevention of Thromboembolism in Atrial Fibrillation, Pulmonary Embolism - First Event, Pulmonary Embolism - Recurrent Event, Thromboembolic Stroke Prophylaxis

Jantoven patient information at Drugs.com